JW Shinyak: Q1 2026 Revenue Up 8.8%, Operating Profit Surges, Financial Structure Improves

Q1 2026 revenue: KRW 21.4bn (up 8.8% YoY from KRW 19.7bn); operating profit: KRW 2.9bn (approx. 4.3x increase from KRW 0.7bn in Q1 2025)
Net income: KRW 2.7bn (down from KRW 8.5bn in Q1 2025, which included a KRW 8.7bn gain from subsidiary liquidation)
Total equity: KRW 42.9bn (up 5.3% from KRW 40.7bn at year-end 2025); accumulated deficit improved to -KRW 51.3bn from -KRW 53.4bn
Hybrid securities of KRW 35bn classified as equity; 5% stock dividend (무상증자) in December 2025
R&D: Joint development agreement with Mujin Medi for topical hair loss treatment AD-303
No pending lawsuits or contingent liabilities
No dividends or share buyback/cancellation

ADVERTISEMENT (250px+)